Cargando…
A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization
Elevated vascular endothelial growth factor (VEGF) and complement activation are implicated in the pathogenesis of different ocular diseases. The objective of this study was to investigate the hypothesis that dual inhibition of both VEGF and complement activation would confer better protection again...
Autores principales: | Li, Yiming, Zhu, Ping, Verma, Amrisha, Prasad, Tuhina, Deng, Hongxin, Yu, Dechao, Li, Qiuhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543459/ https://www.ncbi.nlm.nih.gov/pubmed/28332318 http://dx.doi.org/10.1111/jcmm.13086 |
Ejemplares similares
-
Expression and cellular localization of the Mas receptor in the adult and developing mouse retina
por: Prasad, Tuhina, et al.
Publicado: (2014) -
Amyloid β peptides overexpression in retinal pigment epithelial cells via AAV-mediated gene transfer mimics AMD-like pathology in mice
por: Prasad, Tuhina, et al.
Publicado: (2017) -
Choroidal neovascularization secondary to ocular syphilis
por: Świerczyńska, Marta Paula, et al.
Publicado: (2021) -
Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene Therapy
por: Askou, Anne Louise, et al.
Publicado: (2019) -
Blocking Ocular Sympathetic Activity Inhibits Choroidal Neovascularization
por: Martinez-Camarillo, Juan Carlos, et al.
Publicado: (2022)